RoenRx Review

Our assessment

RoenRx sells the insurance route first and a compounded cash lane behind it, and its terms are unusually plain about what a compounded product actually is. It is also, going by its own pages, running a competitor's website: the page where you choose a treatment greets you as a member of Zealthy, and so does the FAQ, and so does the footer. Its cheapest advertised figure isn't a price at all — it's an insurance copay printed in the same style as one.

A page that thinks you are someone else's customer

The weight-loss page opens with a heading naming a different company as the one whose treatment plan starts here, and it does so twice before any product appears. The weight-loss FAQ says most of that other company's members start on a compounded GLP-1. The footer invites clinicians to join that other company's provider team.

Zealthy is a seller reviewed on this site under a different legal entity. RoenRx's own privacy policy names the company behind Zealthy among its partners, so the two are connected commercially. They are not the same business, and the pages never say they are.

Whatever the arrangement is, the page that asks for your card is telling you, in its own words, that you're somewhere else.

The cheapest number is not a price

The tile carrying the lowest figure sits under a heading reading With Insurance and lists four brand-name drugs. The FAQ explains it as a copay some members may pay depending on their plan, once a coordinator has worked the coverage.

That figure belongs to an insurer, not to RoenRx. Don't subtract it from the cash price either. The gap between the two isn't a saving you can act on.

The same page names the figure the copay is reducing, and the gap between the two is more than fiftyfold. Reading them as two prices for the same thing is exactly the mistake the layout invites.

The cash lane, and the condition attached to it

A compounded semaglutide figure appears on the tile and again in the FAQ, and both times the condition is printed beside it: the rate holds when you buy a three-month supply. A compounded tirzepatide figure appears only in the FAQ.

Oddly, the compounded semaglutide tile also carries the With Insurance label, while the FAQ presents the same figure as the route for members who aren't using insurance. The page contradicts itself about which regime the number belongs to.

A membership exists and its first month is discounted. What it costs after that is never published, and the FAQ states that medication isn't included in it.

Who is behind it

The terms are unusually direct about the regulatory position, stating in one sentence that RoenRx offers compounded semaglutide and tirzepatide and that those are not FDA-approved. Few sellers here put it that plainly.

The corporate name appears in three forms across the site, differing in whether the word Health is present and where the commas fall, and a street address appears in the footer. The clinical work is attributed to two named professional entities.

No compounding pharmacy is named, no list of served states appears, and no prescribing clinician is named. RoenRx carries an FDA warning letter issued in June 2026 over false and misleading claims and misbranding. That is a disclosure, and it doesn't move its position here.